◼ Archived
Health
🔮 fades ✓
The evidence suggesting GLP-1s can curb drug and alcohol cravings
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Glp-1
141 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Glp-1
This hub groups 141 separate news trends connected to Glp-1, spanning June 18, 2026 through October 8, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 1,075 article observations and 1,019 source signals, led by Health, Business, Entertainment coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
High cost of GLP-1s drives some to seek cheaper, unregulated versions
15M Americans take GLP-1 drugs, with some seeking cheaper alternatives due to high costs.
◼ Archived
Business
🔮 fades ✓
PepsiCo cuts earnings forecast as North American turnaround takes longer than expected
PepsiCo cuts earnings forecast
▲ Peaking
Health
🔮 fades ✓
Scientists May Have Found How to Limit Weight Regain After Stopping GLP-1s
Scientists may have found a way to limit weight regain after stopping GLP-1 medications.
▲ Peaking
Health
🔮 fades ✓
Some who take GLP-1s are suffering serious side effects, but it's unclear how often
7 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
▲ Peaking
Health
🔮 fades ✓
Probing the many benefits of GLP-1 receptor agonists
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Austin father loses vision after taking Wegovy; questions raised about rare condition
Rare vision risk linked to GLP-1 drugs sparks concern
◼ Archived
Health
🔮 fades ✓
Scientists uncover a clue that could hint at why we regain weight after diets
A $4 million study is underway to unravel why weight returns after stopping GLP-1 drugs.
◼ Archived
Business
🔮 fades ✓
America’s Restaurants Face a Dilemma: How to Sell Food in the GLP-1 Era
Restaurants adapt to the GLP-1 era, a shift driven by the increasing popularity of weight loss medications.
◼ Archived
Health
🔮 fades ✓
Taking Ozempic or Wegovy? 2 New Studies Link GLP-1 Drugs to 2 Unexpected Problems
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Rapid weight loss on popular drugs could ‘starve’ the brain, expert warns
Popular weight loss drugs may have unintended side effects.
◼ Archived
Health
🔮 fades ✓
Nail detachment over four times more common among GLP-1 users, first controlled study finds
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Dad claims he went suddenly, permanently blind from Ozempic — in one of hundreds of lawsuits against GLP-1 makers
A wave of lawsuits alleging permanent blindness from Ozempic fuels new medical warnings and risk‑assessment tests.
◼ Archived
Health
🔮 fades ✓
Navigating GLP-1 Switches: A Guide for Primary Care
Thousands of people are struggling to maintain weight loss after switching from GLP-1 medications.
◼ Archived
Health
🔮 fades ✓
Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'
GLP-1s shift from 'patients' to 'customers' as weight loss trend surges
◼ Archived
Health
🔮 fades ✓
Does GLP-1 use result in significant hair loss?
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
GLP-1 lawsuit: Patient’s attorney describes life-changing effects from taking drug
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
McDonald’s takes on Starbucks, Chipotle with big new menu debuts
McDonald’s overhauls menu for weight-conscious consumers.
◼ Archived
Health
🔮 fades ✓
Is long-term use of GLP-1s safe?
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
McDonald's is exploring ways to attract GLP-1 users
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
GLP-1 Users Are Furious After Employers Drop Insurance Benefits
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Some GLP-1 companies facing lawsuits over vision loss. What to know
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1 prescriptions for people with no medical need are climbing
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
Study finds link between GLP-1 drugs and nutritional deficiencies in children
◼ Archived
Health
🔮 fades ✓
The Best Strength Training Exercises for People Taking GLP-1s, According to an Expert
Expert advice for people taking GLP-1 medications to avoid malnourishment and muscle loss.
◼ Archived
Health
🔮 fades ✓
The dangerous risks of stopping Ozempic and GLP-1s
18 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
‘Boom, lights out’: Massachusetts man shares sudden blindness journey after taking GLP-1
Massachusetts man shares sudden blindness journey after taking GLP-1, sparking lawsuits and safety concerns.
◼ Archived
Business
🔮 fades ✓
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
700,000 seniors start GLP-1 treatments under Medicare, with 70% on Eli Lilly drugs
◼ Archived
Business
🔮 fades ✓
The company behind a new GLP-1 pill is betting $6.5 billion on Houston
Eli Lilly stakes $6.5 billion on a Houston plant as its GLP‑1 drugs dominate Medicare prescriptions
◼ Archived
Business
🔮 fades ✓
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Millions of parents are taking GLP-1s. How should they talk to their kids about it?
GLP-1s linked to nutritional deficiencies in nearly 1 in 6 children, raising questions about parental conversations.
◼ Archived
Health
🔮 fades ✓
Large genetic study links GLP-1 receptor activation to improved mental well-being
Genetic link between GLP-1 receptor activation and better mental well‑being sparks new buzz in diabetes drugs
◼ Archived
Business
🔮 fades ✓
Health insurers covered 112,000 fewer Mass. residents’ GLP-1 weight-loss drugs this year, report finds
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Will Wegovy Be A Part D, A Medicare GLP-1 Bridge Drug Or Neither?
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
What Really Disappears When You Lose Weight on GLP-1 Drugs?
10 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
9 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
GLP‑1 hype meets science as demand spikes, safety debates and efficacy doubts flood the media
◼ Archived
Business
🔮 fades ✓
The weight I lost with GLP-1s came back ‘with taxes’
Weight lost on GLP‑1 drugs often returns faster than it vanished, sparking a new debate on lasting obesity treatment.
◼ Archived
Health
🔮 fades ✓
GLP-1 drugs dubbed ‘fountain of youth’ as doctors share surprising benefits beyond weight loss
Doctors label GLP‑1 drugs a 'fountain of youth' as research flags cognitive and reproductive perks beyond slimming
◼ Archived
Health
🔮 fades ✓
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
New era of obesity medicines raises hopes for broader health benefits beyond weight loss.
◼ Archived
Health
🔮 fades ✓
Popular GLP-1 drugs may trigger a rare, life-threatening brain disorder: study
Popular GLP-1 drugs linked to life-threatening brain disorder and suicidal thoughts after weight regain.
◼ Archived
Health
🔮 fades ✓
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
Weight regain after obesity drugs spikes risk of suicidal thoughts, study finds
◼ Archived
Health
🔮 fades ✓
GLP-1 prescriptions for kids up more than 30,000% since 2019
GLP-1 prescriptions for kids surge by over 30,000% since 2019
◼ Archived
Health
🔮 fades ✓
GLP-1 weight-loss drugs show promise for sleep apnea
GLP-1 weight-loss drugs could cut sleep-apnea rates, opening a new market and clinical pathway for millions.
◼ Archived
Business
🔮 fades ✓
Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Novo’s child obesity win sparks hope, but simultaneous heart‑drug trial cuts cloud its broader pipeline.
◼ Archived
Health
🔮 fades ✓
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Weight-loss drugs not working as expected lead to withdrawal-like cravings and unexpected side effects.
◼ Archived
Health
🔮 fades ✓
More children under 12 in US are being prescribed weight-loss drugs, study finds
US prescriptions for weight-loss drugs in children under 12 are increasing, according to a recent study.
◼ Archived
Health
🔮 fades ✓
Scientists Discover an Unexpected Mental Health Benefit of Ozempic
Ozempic may boost mental health, sparking debate over GLP‑1 drugs' psychological impact
◼ Archived
Health
🔮 fades ✓
GLP-1 medications may worsen or speed hair loss in some men, study finds
GLP-1 medications may worsen or speed hair loss in some men, study finds.
◼ Archived
Health
🔮 fades ✓
Don’t take GLP-1s? Be prepared to explain yourself.
A surge in GLP‑1 prescriptions turns personal weight‑loss choices into a public debate demanding explanations.
◼ Archived
Business
🔮 fades ✓
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Investors in Novo Nordisk are on edge as the pharmaceutical giant faces increasing competition in the GLP-1 market.
◼ Archived
Health
🔮 fades ✓
GLP-1s may work by activating an unlikely weight loss ally
Recent scientific findings reveal specific brain mechanisms and proteins influencing fatty food cravings and weight loss treatments.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight loss drugs effective even at low starter doses
Low‑dose GLP‑1 therapies may unlock weight loss with less drug, reshaping treatment standards
◼ Archived
Health
🔮 fades ✓
Experts call for safer weight loss as concerns grow over GLP-1 use - News-Medical
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
I lost the weight on a GLP-1
Men’s weight‑loss drugs face a double‑edge of stigma and rebound fears as GLP‑1 use spikes.
◼ Archived
Health
🔮 fades ✓
Weight Down, Steps Down: The GLP-1 Catch
GLP-1 drugs, known for weight loss, may also reduce physical activity, sparking debate among health experts.
◼ Archived
Health
Ozempic may help people with serious mental health condition: study
People with serious mental health conditions may soon have a new treatment option.
◼ Archived
Health
🔮 fades ✓
The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don’t Qualify
Millions of Medicare patients with qualifying diagnoses are excluded from a new GLP-1 discount program.
◼ Archived
Health
🔮 fades ✓
Are GLP-1 Drugs a ‘Fountain of Youth’? Doctors Explain Health Benefits Beyond Weight Loss
Doctors are exploring health benefits of GLP-1 drugs beyond weight loss, sparking debate on their potential as a 'fountain of youth'.
◼ Archived
Health
Is the US seeing a turning point in obesity rates?
New research and drugs are challenging long-held beliefs about weight loss and obesity in the US.